Foundation for innovation
in Cardiometabolism and Nutrition

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure Rationale and design of the randomized AFLOAT study

European Heart Journal – Cardiovascular Pharmacotherapy

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure Rationale and design of the randomized AFLOAT study

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network